The present study investigated whether the above-described effects on GBM cells were direct results of SOCE inhibition, by a) studying the molecular mechanisms and specificity of Synta66 binding to the SOC complex and, b) observing the direct effects of Synta66-mediated SOC inhibition in three GBM cell lines. The gene discussed is UBXN11; the disease is glioblastoma.